To examine the safety and preliminary efficacy of multiple adjunctive host directed TB
therapies (TB HDT), to assess their potential to shorten TB treatment and/or prevent
permanent lung damage.
Phase:
Phase 2
Details
Lead Sponsor:
The Aurum Institute NPC
Treatments:
Auranofin Cholecalciferol Ergocalciferols Everolimus Rifabutin Sirolimus Vitamin D Vitamins